Inventor
ULLRICH AXEL
DE91 patents
⚠️ This page may combine multiple inventors who share the name “ULLRICH AXEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
20 patentsUS6399063B1Jun 4, 2002
Monoclonal antibodies directed to the HER2 receptor
GENENTECH INC282 citations99
US6387371B1May 14, 2002
Monoclonal antibodies directed to the HER2 receptor
GENENTECH INC272 citations99
US6165464ADec 26, 2000
Monoclonal antibodies directed to the HER2 receptor
GENENTECH INC363 citations99
US5772997AJun 30, 1998
Monoclonal antibodies directed to the HER2 receptor
GENENTECH INC437 citations99
US5770195AJun 23, 1998
Monoclonal antibodies directed to the her2 receptor
GENENTECH INC492 citations99
US5725856AMar 10, 1998
Monoclonal antibodies directed to the HER2 receptor
GENENTECH INC516 citations99
US5720954AFeb 24, 1998
Monoclonal antibodies directed to the HER2 receptor
GENENTECH INC328 citations99
US5720937AFeb 24, 1998
In vivo tumor detection assay
GENENTECH INC224 citations99
US5677171AOct 14, 1997
Monoclonal antibodies directed to the HER2 receptor
GENENTECH INC924 citations99
US4761371AAug 2, 1988
Insulin receptor
GENENTECH INC168 citations98
US6333169B1Dec 25, 2001
HER2 extracellular domain
GENENTECH INC151 citations97
US6015567AJan 18, 2000
HER2 extracellular domain
GENENTECH INC283 citations97
US4859609AAug 22, 1989
Novel receptors for efficient determination of ligands and their antagonists or agonists
GENENTECH INC236 citations97
US5169762ADec 8, 1992
Human nerve growth factor by recombinant technology
GENENTECH INC41 citations95
US5030576AJul 9, 1991
Receptors for efficient determination of ligands and their antagonists or agonists
GENENTECH INC84 citations94
US5288622AFeb 22, 1994
Human nerve growth factor by recombinant technology
GENENTECH INC30 citations92
US6235498B1May 22, 2001
Method for culturing recombinant cells
GENENTECH INC14 citations82
US6399331B2Jun 4, 2002
Method for culturing recombinant cells
GENENTECH INC7 citations74
US6331414B1Dec 18, 2001
Preparation of human IGF via recombinant DNA technology
GENENTECH INC9 citations74
US6232117B1May 15, 2001
Method for culturing recombinant cells
GENENTECH INC8 citations74
MAX PLANCK GESELLSCHAFT
13 patentsUS6177401B1Jan 23, 2001
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
MAX PLANCK GESELLSCHAFT123 citations97
US5851999ADec 22, 1998
FLK-1 is a receptor for vascular endothelial growth factor
MAX PLANCK GESELLSCHAFT160 citations97
US7531304B2May 12, 2009
Method for screening FGFR-4 agonists
MAX PLANCK GESELLSCHAFT35 citations92
US6030822AFeb 29, 2000
Extracellular signal-regulated kinase, sequences, and methods of production and use
MAX PLANCK GESELLSCHAFT34 citations92
US5589375ADec 31, 1996
PTP 1D: a novel protein tyrosine phosphatase
MAX PLANCK GESELLSCHAFT31 citations92
US7297774B2Nov 20, 2007
Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer
MAX PLANCK GESELLSCHAFT26 citations91
US6770742B1Aug 3, 2004
Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer
MAX PLANCK GESELLSCHAFT15 citations91
US5952212ASep 14, 1999
Protein tyrosine phosphatase
MAX PLANCK GESELLSCHAFT19 citations90
US8043806B2Oct 25, 2011
Method of diagnosing an RTK-hyperfunction induced disorder
MAX PLANCK GESELLSCHAFT7 citations82
US5981251ANov 9, 1999
PTP 1D: a novel protein tyrosine phosphatase
MAX PLANCK GESELLSCHAFT15 citations82
US6004791ADec 21, 1999
Protein tyrosine phosphatase PTP20 and related products and methods
MAX PLANCK GESELLSCHAFT15 citations80
US5459036AOct 17, 1995
Extracellular signal-regulated kinase, sequences, and methods of production and use
MAX PLANCK GESELLSCHAFT15 citations79
US5955592ASep 21, 1999
Nucleic acid encoding novel protein phosphotyrosine phosphatase PTP-D1
MAX PLANCK GESELLSCHAFT16 citations78
SUGEN INC
5 patentsUS5700823ADec 23, 1997
Treatment of platelet derived growth factor related disorders such as cancers
SUGEN INC122 citations98
US6326469B1Dec 4, 2001
Megakaryocytic protein tyrosine kinases
SUGEN INC184 citations96
US5990141ANov 23, 1999
Treatment of platelet derived growth factor related disorders such as cancers
SUGEN INC189 citations96
US5932602AAug 3, 1999
Treatment of platelet derived growth factor related disorders such as cancers
SUGEN INC26 citations92
US5958959ASep 28, 1999
Treatment of platelet derived growth factor related disorders such as cancers
SUGEN INC15 citations81
UNIV CALIFORNIA
4 patentsUS4440859AApr 3, 1984
Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
UNIV CALIFORNIA170 citations97
US6331555B1Dec 18, 2001
Treatment of platelet derived growth factor related disorders such as cancers
UNIV CALIFORNIA152 citations94
US5700822ADec 23, 1997
Treatment of platelet derived growth factor related disorders such as cancers
UNIV CALIFORNIA67 citations94
US4652525AMar 24, 1987
Recombinant bacterial plasmids containing the coding sequences of insulin genes
UNIV CALIFORNIA50 citations94
ICRF PATENTS LIMITED
1 patentUNIV NEW YORK
1 patent(unassigned)
1 patentBOEHRINGER MANNHEIM GMBH
1 patentMAX PLANCK GELLSCHAFT ZUR FODE
1 patentEBERHARD KARLS UNI TUBINGEN UN
1 patentSCHULTZ-FADEMRECHT CARSTEN
1 patentULLRICH AXEL
1 patentShowing the top 50 of 91 patents by PatentIndex Score.